SR0019LRB103 25946 ECR 52298 r


  
1
SENATE RESOLUTION

  
 
2    WHEREAS, Pancreatic cancer is the third leading cause of 
3cancer-related deaths in the U.S. and is projected to be the 
4second leading cause of cancer-related deaths by 2030; and
  
 
5    WHEREAS, Pancreatic cancer is one of the deadliest cancers 
6and has the lowest five-year survival rate at just 10%; and
  
 
7    WHEREAS, In 2023, an estimated 60,430 U.S. residents will 
8be diagnosed with pancreatic cancer, and more than 48,220 will 
9die from the disease; and
  
 
10    WHEREAS, Due to increased awareness, pancreatic cancer 
11survival rates have been improving; however, the disease is 
12still considered largely incurable; with all stages of 
13pancreatic cancer combined, the one-year relative survival 
14rate is 20% and the five-year rate is 9%; and
  
 
15    WHEREAS, The problem is that high-risk people are not 
16being screened in the early and potentially curable stages of 
17pancreatic cancer; and
  
 
18    WHEREAS, Risk factors can include chronic or hereditary 
19pancreatitis, obesity, regular consumption of high dietary 
20fats, alcohol abuse, smoking, family history, age, and 
 
 
SR0019- 2 -LRB103 25946 ECR 52298 r

1long-standing diabetes; and
  
 
2    WHEREAS, Symptoms can include abdominal pain, mid-to-upper 
3back pain, weight loss,  jaundice that is yellowing of the skin 
4and eyes, nausea, loss of appetite, changes in stool, and 
5new-onset diabetes; and
  
 
6    WHEREAS, Early screening will save lives; therefore, be it
  
 
7    RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL 
8ASSEMBLY OF THE STATE OF ILLINOIS, that we declare the month of 
9November 2023 as Pancreatic Cancer Awareness Month in the 
10State of Illinois; and be it further
  
 
11    RESOLVED, That suitable copies of this resolution be 
12presented to the Pancreatic Cancer Action Network (PanCAN), 
13the American Cancer Society, and Dr. Paul Grippo of the 
14University of Illinois at Chicago with our sincere 
15appreciation for their efforts to address pancreatic cancer.